[SMC] Congenital myasthenic syndrome in a cohort of patients with 'double' seronegative myasthenia gravis
Posté : 21 déc. 2021 12:00
Arq Neuropsiquiatr. 2021 Dec 17:S0004-282X2021005028203. doi: 10.1590/0004-282X-ANP-2020-0575. Online ahead of print.
ABSTRACT
BACKGROUND: Congenital myasthenic syndromes (CMS) have some phenotypic overlap with seronegative myasthenia gravis (SNMG).
OBJECTIVE: The aim of this single center study was to assess the minimum occurrence of CMS misdiagnosed as double SNMG in a Brazilian cohort.
METHODS: The genetic analysis of the most common mutations in CHRNE, RAPSN, and DOK7 genes was used as the main screening tool.
RESULTS: We performed genetic analysis in 22 patients with a previous diagnosis of 'double' SNMG. In this study, one CMS patient was confirmed due to the presence of compound heterozygous variants in the CHRNE gene (c.130insG/p.Cys210Phe).
CONCLUSIONS: This study confirmed that CMS due to CHNRE mutations can be mistaken for SNMG. In addition, our study estimated the prevalence of misdiagnosed CMS to be 4.5% in 'double' SNMG patients of our center. Based on our findings, genetic screening could be helpful in the diagnostic workup of patients with 'double' SNMG in whom differential diagnosis is recommended.
PMID:34932651 | DOI:10.1590/0004-282X-ANP-2020-0575
Source: https://pubmed.ncbi.nlm.nih.gov/3493265 ... 0&v=2.17.5